Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | 0 | -1,184 |
| Accounts payable and accrued liabilities | N/A | 181 |
| Other Working Capital | 0 | 634 |
| Other Operating Activity | 0 | -141 |
| Operating Cash Flow | $0 | $-510 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $0 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | N/A | 2 |
| Other Financing Activity | 0 | 6,099 |
| Financing Cash Flow | $0 | $6,101 |
| End Cash Position | 0 | 5,591 |
| Net Cash Flow | $0 | $5,591 |
| Free Cash Flow | ||
| Operating Cash Flow | 0 | -510 |
| Free Cash Flow | 0 | -510 |